GlassScriptPhysician profile
Richard J Goldstein
NPI 1821181082
$57,224.46
in general payments reported to CMS, 2019-2025
53 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,795 · 2020: $2,103 · 2021: $4,036 · 2022: $9,755 · 2023: $5,121 · 2024: $15K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Consulting Fee: $11K · Travel and Lodging: $8,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,436.24 |
| Consulting Fee | $10,855.00 |
| Travel and Lodging | $8,244.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $19,657.88 | 2019-2025 | |
| Integra Lifesciences Corporation | $16,325.40 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $5,883.73 | 2019-2025 | Collagenase Santyl, Regranex, Stravix Pl |
| Trice Medical, INC. | $2,149.62 | 2024-2025 | |
| Tactile Systems Technology INC | $2,049.75 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Organogenesis INC. | $1,641.63 | 2019-2025 | Puraply Wound Matrix, Apligraf, Puraply |
| Abbott Laboratories | $1,572.79 | 2019-2025 | Supera, Esprit, Diamondback Peripheral |
| Crossroads Extremity Systems, LLC | $1,144.38 | 2019-2021 | |
| Kerecis Limited | $882.28 | 2020-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Cardiovascular Systems INC. | $804.79 | 2019-2022 | |
| Medtronic, INC. | $767.72 | 2022-2025 | Pacific Xtreme, Silverhawk, Hawkone |
| Stryker Corporation | $719.81 | 2019-2025 | Citrefix, Infinity Adaptis, Infinity |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $513.85 | 2019-2025 | Jublia |
| Resmed Corp | $342.41 | 2023 | |
| Paratek Pharmaceuticals, INC. | $216.31 | 2021-2023 | Nuzyra |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $204.25 | 2021-2025 | |
| Extremity Medical | $183.07 | 2024 | |
| Grt US Holding, INC. | $166.78 | 2022-2025 | Qutenza |
| Biocomposites INC | $164.41 | 2024-2025 | Stimulan |
| Linvatec Corporation | $156.36 | 2025 | Hercules Syndesmosis Implant System, Fracture and Correction Colag 2, Allograft Tissue |
| Urgo Medical North America, LLC | $150.71 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Sandoz INC. | $137.26 | 2019-2025 | Jubbonti |
| Fusion Orthopedics USA, LLC | $123.06 | 2024 | |
| Horizon Therapeutics Plc | $114.47 | 2019-2020 | |
| Asensus Surgical, INC. | $108.66 | 2022-2024 | Senhance |
| Orthofix Medical, INC. | $105.31 | 2019 | |
| Fidia Pharma USA INC. | $91.21 | 2019-2020 | |
| Sebela Pharmaceuticals INC. | $86.46 | 2020-2023 | Pramosone, Naftin |
| Zimmer Biomet Holdings, INC. | $79.44 | 2021 | |
| Glaxosmithkline, LLC. | $73.43 | 2022-2023 | Trelegy Ellipta, Bexsero, Shingrix |
| Boston Scientific Corporation | $63.13 | 2019 | |
| Melinta Therapeutics, LLC | $62.01 | 2019 | |
| Mallinckrodt Hospital Products INC. | $46.76 | 2022 | |
| Kci USA, INC. | $38.51 | 2021 | |
| Hartmann USA, INC. | $30.97 | 2022-2024 | Zetuvit Plus 10x10 P10 |
| Alexion Pharmaceuticals, INC. | $30.28 | 2019-2022 | |
| Janssen Biotech, INC. | $29.20 | 2019 | |
| Bioventus LLC | $27.25 | 2019 | |
| Journey Medical Corporation | $26.87 | 2020 | |
| Wright Medical Technology, INC. | $26.33 | 2019 | |
| Heron Therapeutics, INC. | $26.07 | 2021 | |
| Hydrofera LLC | $25.59 | 2024 | Hydrofera Blue |
| Medartis INC. | $22.77 | 2022 | |
| Inspire Medical Systems, INC. | $19.32 | 2024 | Inspire |
| Novartis Pharmaceuticals Corporation | $17.41 | 2021 | |
| Royal Biologics, INC. | $16.00 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $15.97 | 2023 | Seglentis |
| Amarin Pharma, INC. | $15.00 | 2021 | |
| Merck Sharp & Dohme LLC | $14.97 | 2021 | |
| Reprise Biomedical, INC. | $14.39 | 2020 | |
| Amgen INC. | $14.02 | 2022 | |
| Averitas Pharma INC. | $12.81 | 2023 | Qutenza |
| Polarityte, INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.